Intelligence · Clinical Development
Pipeline search results
Programs matching “recombinant” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 118 pipeline programs matching "recombinant" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Commercial Hylenex® recombinant (hyaluronidase human injection)
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
HCV-001
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis B Vaccines
1 trial -
Isotonic hydration fluid and recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]
Takeda
Hemophilia A
2 trials -
Recombinant FSH (follitropin alpha)
United Therapeutics Europe Ltd
Ovulation Induction
1 trial -
Recombinant Human Adenovirus Type 5 injection
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Recombinant Protein-Free Factor VIII (rAHF-PFM)
Takeda
Hemophilia A
1 trial -
Recombinant Staphylokinase
The First People's Hospital of Lianyungang
ST-segment Elevation Myocardial Infarction (STEMI)
1 trial -
Recombinant Staphylokinase
The First People's Hospital of Lianyungang
Acute Myocardial Infarction
1 trial -
Recombinant human growth hormone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Achondroplasia
1 trial -
Recombinant human growth hormone (r-hGH)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dwarfism, Pituitary
1 trial -
Recombinant staphylokinase
The First People's Hospital of Lianyungang
ST Elevation Myocardial Infarction
1 trial -
Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)
United Therapeutics Europe Ltd
Diarrhea
1 trial -
Recombinant tissue plasminogen activator (rt-PA)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Thromboembolisms
1 trial -
hyaluronidase (human recombinant)/rehydration fluid
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
recombinant human erythropoietin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Premature Birth
1 trial -
recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Healthy
1 trial -
recombinant human thrombopoietin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thrombocytopenia
1 trial -
Intrathecal recombinant human alpha iduronidase
Ultragenyx UK Limited
Mucopolysaccharidosis I
1 trial -
Recombinant COVID-19 Vaccine (Sf9 Cell)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Sucrose Iron，subcutaneous recombinant human erythropoietin，intravenous vitamin C
The First People's Hospital of Lianyungang
Anemia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.